Schedule 13G ownership disclosure

PROPANC BIOPHARMA INC

Common Stock, par value $0.001 per share · CUSIP: 74346N701

Event date: 2025-08-14

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Ionic Ventures, LLC

    Shares: 1,257,622.00 · Class: 9.9%

  • Ionic Management, LLC

    Shares: 1,257,622.00 · Class: 9.9%

  • Brendan O'Neil

    Shares: 1,257,622.00 · Class: 9.9%

  • Keith Coulston

    Shares: 1,257,622.00 · Class: 9.9%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001753926-25-001357
Form type
SCHEDULE 13G
Filer
Ionic Ventures, LLC
CIK
CIK 1769419
Filed
Aug 19, 2025
Reporting period
Aug 14, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub